IDENTIFICATION OF FACTOR THAT PROMOTES HUMAN HSC SELF-RENEWAL
- 专利权人:
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- 发明人:
- MIKKOLA, Hanna,CALVANESE, Vincenzo,NGUYEN, Andrew T.
- 申请号：
- IBIB2017/053607
- 公开号：
- WO2017/216775A3
- 申请日:
- 2017.06.16
- 申请国别(地区):
- WO
- 年份:
- 2018
- 代理人:
- 摘要：
- Transient MLLT3 overexpression in culture may be used to expand human HSCs in vitro, and thereby improve the efficiency and safety of HSC transplantation.La surexpression de MLLT3 transitoire en culture peut être utilisée pour multiplier les cellules souches hématopoïétiques humaines in vitro, et ainsi améliorer lefficacité et la sécurité de la transplantation de HSC.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- process of radionuclide labeling of murine or human, monoclonal or polyclonal anti-tumor necrosis factor associated with diseases whose pathophysiology involves tumor necrosis factor； reagent for diagnosis "in vivo" and / or "in vitro" based on murine or human antibodies, monoclonal or polyclonal anti-tumor necrosis factor associated with radionuclides； diagnostic methods "in vitro" and / or "in vivo" of diseases whose physiotopagenia involves tumor necrosis factor using the reagent thus obtained and kit for diagnosing diseases whose pathophysiology involves tumor necrosis factor based on said
- DIFFERENCIATION PANCREATIQUE IN VITRO DES CELLULES PLURIPOTENTES DE MAMMIFÈRES
- МАРКЕРНЫЕ ГЕНЫ ДЛЯ ПРИМЕНЕНИЯ В ИДЕНТИФИКАЦИИ ФЕНОТИПИЧЕСКОЙ СТАБИЛЬНОСТИ ХОНДРОЦИТОВ И В СКРИНИНГЕ ФАКТОРОВ, ВЛИЯЮЩИХ НА ПРОДУЦИРОВАНИЕ ХРЯЩА
- In Vitro Pancreatic Differentiation of Pluripotent Mammalian Cells
- תרכובות ביאריל, תכשירי רוקחות המכילים אותן, שמוש בתרכובות כאלה לייצור תרופות ושיטות in vitro והתקנים המשתמשים בתרכובות כאלה
